CTS PSC Cryomedium is a cGMP-manufactured, ready-to-use, xeno-free solution for the cryopreservation of early passage pluripotent stem cells (PSCs). CTS PSC Cryomedium helps minimize loss of cell viability and maximize post-thaw recovery. For the cryopreservation and recovery of PSCs, use the CTS PSC Cryopreservation Kit.
CTS PSC Cryomedium: • Provides efficient recovery and higher viability than traditional methods of PSC cryopreservation • Facilitates regulatory filings through cGMP manufacturing and the availability of documentation • Simplifies the transition from bench to clinic through the direct replacement of RUO PSC Cryopreservation Medium
Efficient recovery CTS PSC Cryomedium routinely achieves higher viability than traditional methods of cryopreservation and is compatible with clump and single cell passaged PSCs cultured in a variety of media systems. CTS PSC Cryomedium is provided as a ready-to-use, complete solution containing 10% DMSO for efficient cell addition. Separate additions of enhancing reagents are not required, helping save valuable preparation time.
Facilitates regulatory filings CTS PSC Cryomedium is manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing site is ISO 13485-certified. Full documentation traceability and convenient access to our Drug Master File (DMF) are available for CTS PSC Cryomedium.
Simplifies transition from bench to clinic With its extensive safety testing, including adventitious agents, CTS PSC Cryomedium enables a smooth transition from RUO PSC Cryopreservation Medium.
For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.